Massachusetts Financial Services Co. MA acquired a new stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) during the third quarter, HoldingsChannel reports. The firm acquired 292,695 shares of the company’s stock, valued at approximately $11,090,000.
Other hedge funds also recently modified their holdings of the company. Raymond James & Associates raised its position in Prestige Consumer Healthcare by 36.1% during the second quarter. Raymond James & Associates now owns 45,163 shares of the company’s stock valued at $1,733,000 after purchasing an additional 11,989 shares during the period. Janus Henderson Group PLC raised its position in Prestige Consumer Healthcare by 10.4% during the second quarter. Janus Henderson Group PLC now owns 943,042 shares of the company’s stock valued at $36,194,000 after purchasing an additional 88,822 shares during the period. Flinton Capital Management LLC raised its position in Prestige Consumer Healthcare by 32.0% during the second quarter. Flinton Capital Management LLC now owns 31,776 shares of the company’s stock valued at $1,220,000 after purchasing an additional 7,696 shares during the period. Dimensional Fund Advisors LP raised its position in Prestige Consumer Healthcare by 37.7% during the second quarter. Dimensional Fund Advisors LP now owns 3,199,714 shares of the company’s stock valued at $122,805,000 after purchasing an additional 876,192 shares during the period. Finally, Dalton Greiner Hartman Maher & Co. purchased a new stake in Prestige Consumer Healthcare during the third quarter valued at approximately $16,851,000.
A number of equities research analysts have issued reports on the company. DA Davidson upped their price objective on Prestige Consumer Healthcare to $38.00 and gave the company a “neutral” rating in a research report on Monday. Jefferies Financial Group set a $38.00 price objective on Prestige Consumer Healthcare and gave the company a “hold” rating in a research report on Thursday, August 2nd. Zacks Investment Research downgraded Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 10th. Finally, ValuEngine raised Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research note on Thursday, October 11th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $72.40.
Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, November 1st. The company reported $0.65 EPS for the quarter, beating analysts’ consensus estimates of $0.63 by $0.02. The firm had revenue of $239.36 million for the quarter, compared to analysts’ expectations of $236.28 million. Prestige Consumer Healthcare had a return on equity of 11.82% and a net margin of 33.38%. The company’s quarterly revenue was down 7.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.61 earnings per share. As a group, equities research analysts predict that Prestige Consumer Healthcare Inc will post 2.88 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “Massachusetts Financial Services Co. MA Acquires New Stake in Prestige Consumer Healthcare Inc (PBH)” was originally reported by Week Herald and is the property of of Week Herald. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://weekherald.com/2018/11/07/massachusetts-financial-services-co-ma-acquires-new-stake-in-prestige-consumer-healthcare-inc-pbh.html.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Featured Article: What are the most popular ETFs
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.